» Articles » PMID: 35461334

PINK1 Ameliorates Acute-on-chronic Liver Failure by Inhibiting Apoptosis Through MTORC2/AKT Signaling

Overview
Date 2022 Apr 24
PMID 35461334
Authors
Affiliations
Soon will be listed here.
Abstract

Acute-on-chronic liver failure (ACLF) is a lethal syndrome with a remarkable short-term death rate. Even worse, effective internal medicine therapies are currently lacking. Increasing evidence indicates apoptosis plays a critical role in the progression of liver failure. PINK1 has an essential function in maintaining cell survival. However, the role and underlying mechanism of PINK1 in apoptosis in ACLF are incompletely understood. Herein, our team discovered that PINK1 remarkably improved ACLF, featured by a reduction in aspartate aminotransferase (AST) and alanine aminotransferase (ALT) and an amelioration in the gross and microscopy histopathology appearance of hepatic tissues. Meanwhile, PINK1 affected cleaved caspase-3 expression via mTORC2/AKT, and this effect was eliminated after further intervention with Rictor or AKT. Overall, these findings indicate that PINK1 participates in the regulation of multiple biological functions, including hepatic cell growth and apoptosis in ACLF via the mTORC2/AKT signaling pathway. The present research offers a solid theory-wise foundation for the clinic applications of PINK1 as a valid target for ACLF treatment to reverse or postpone the development of ACLF.

Citing Articles

The interactive role of microRNA and other non-coding RNA in hepatitis B (HBV) associated fibrogenesis.

Sartorius K, Wang Y, Sartorius B, Antwi S, Li X, Chuturgoon A Funct Integr Genomics. 2025; 25(1):24.

PMID: 39847120 DOI: 10.1007/s10142-024-01519-4.


Exercise, mTOR Activation, and Potential Impacts on the Liver in Rodents.

Onaka G, Carvalho M, Onaka P, Barbosa C, Martinez P, de Oliveira-Junior S Biology (Basel). 2024; 13(6).

PMID: 38927242 PMC: 11201249. DOI: 10.3390/biology13060362.


Alcohol-Associated Liver Disease Outcomes: Critical Mechanisms of Liver Injury Progression.

Osna N, Tikhanovich I, Ortega-Ribera M, Mueller S, Zheng C, Mueller J Biomolecules. 2024; 14(4.

PMID: 38672422 PMC: 11048648. DOI: 10.3390/biom14040404.


FTO attenuates TNF-α-induced damage of proximal tubular epithelial cells in acute pancreatitis-induced acute kidney injury via targeting AQP3 in an N6-methyladenosine-dependent manner.

Li X, Liang Q, Liu L, Chen S, Li Y, Pu Y Ren Fail. 2024; 46(1):2322037.

PMID: 38445367 PMC: 10919303. DOI: 10.1080/0886022X.2024.2322037.


The PTP1B inhibitor MSI-1436 ameliorates liver insulin sensitivity by modulating autophagy, ER stress and systemic inflammation in Equine metabolic syndrome affected horses.

Bourebaba L, Serwotka-Suszczak A, Pielok A, Sikora M, Mularczyk M, Marycz K Front Endocrinol (Lausanne). 2023; 14:1149610.

PMID: 37020593 PMC: 10067883. DOI: 10.3389/fendo.2023.1149610.

References
1.
Wen Y, Zhang J, Kapupara K, Tsai R . mTORC2 activation protects retinal ganglion cells via Akt signaling after autophagy induction in traumatic optic nerve injury. Exp Mol Med. 2019; 51(8):1-11. PMC: 6802655. DOI: 10.1038/s12276-019-0298-z. View

2.
Dai K, Radin D, Leonardi D . Deciphering the dual role and prognostic potential of PINK1 across cancer types. Neural Regen Res. 2020; 16(4):659-665. PMC: 8067949. DOI: 10.4103/1673-5374.295314. View

3.
Lin C, Tsai C . PINK1/parkin-mediated mitophagy pathway is related to neuroprotection by carnosic acid in SH-SY5Y cells. Food Chem Toxicol. 2019; 125:430-437. DOI: 10.1016/j.fct.2019.01.027. View

4.
Xu Y, Tang Y, Lu J, Zhang W, Zhu Y, Zhang S . PINK1-mediated mitophagy protects against hepatic ischemia/reperfusion injury by restraining NLRP3 inflammasome activation. Free Radic Biol Med. 2020; 160:871-886. DOI: 10.1016/j.freeradbiomed.2020.09.015. View

5.
Murata H, Sakaguchi M, Jin Y, Sakaguchi Y, Futami J, Yamada H . A new cytosolic pathway from a Parkinson disease-associated kinase, BRPK/PINK1: activation of AKT via mTORC2. J Biol Chem. 2010; 286(9):7182-9. PMC: 3044975. DOI: 10.1074/jbc.M110.179390. View